VIVS News

VivoSim Platform Predicts Gastrointestinal Toxicity (Diarrhea) in an AI Model Trained on Human Intestinal Model Results – Without Animal Testing

Digital Biomarkers Market worth $17.73 billion by 2031 | MarketsandMarkets™

Form 8-K

VivoSim Announces Pricing of up to a $4 Million Public Offering

VivoSim Releases Antibody Drug Conjugate (ADC) Data Showing Power to Detect ADC Toxicity and Guide Design of Safer ADCs

VivoSim Appoints Arumugham (Ragoo) Raghunathan as Vice President of Global Sales

VivoSim to Debut Antibody Drug Conjugate Data, representing a major new market for NAMkind models, at Society of Toxicology Meeting in San Diego

VivoSim Labs Appoints Amar Sethi, M.D., Ph.D. as Chief Scientific Officer